Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7339 p258
5 March 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Heart failure service extended to Glasgow’s community pharmacists

Community pharmacists across Glasgow will start offering a heart failure service next week. Pharmacists working in GP surgeries and in secondary care in the city have been involved in a heart failure service for some time (PJ, 12 June 2004, p741).

“It is about closing the loop,” explained project co-ordinator Paul Forsyth. “When a specialist prescribing support or hospital pharmacist carries out a medication review for heart failure patients there are often outstanding issues that need to be followed up. These can be tackled by community pharmacists.”

Richard Lowrie, primary care project lead, commented: “This is the first time there has been a proper system for referral to community pharmacists in Glasgow. It is a fantastic opportunity for patients and pharmacists to get involved in an overlooked stage of chronic disease management.”

Patients will be referred to the community pharmacy of their choice by prescribing support pharmacists, hospital pharmacists or heart failure liaison nurses. As well as following up any specified issues, community pharmacists will also carry out an initial assessment to determine a patient’s symptoms and will then monitor progress against this baseline. “The aim is to make interventions that increase adherence as well as identify any problems that need to be referred,” explained Mr Lowrie.

Training sessions were held this week. Altogether, 180 pharmacists booked places from 130 of Glasgow’s 217 community pharmacies. Final negotiations on funding for the service are due to be completed this week. The process is integrated with Glasgow’s heart failure strategy and the project leads, Mr Lowrie and Steve McGlynn, principal pharmacist at North Glasgow University Hospitals, are part of Glasgow’s Heart Managed Clinical Network.

Back to Top


©The Pharmaceutical Journal